<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    8386917
   </pmid>
   <datecreated>
    <year>
     1993
    </year>
    <month>
     05
    </month>
    <day>
     27
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1993
    </year>
    <month>
     05
    </month>
    <day>
     27
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2009
    </year>
    <month>
     11
    </month>
    <day>
     18
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Electronic">
      1468-2044
     </issn>
     <journalissue citedmedium="Internet">
      <volume>
       68
      </volume>
      <issue>
       2
      </issue>
      <pubdate>
       <year>
        1993
       </year>
       <month>
        Feb
       </month>
      </pubdate>
     </journalissue>
     <title>
      Archives of disease in childhood
     </title>
     <isoabbreviation>
      Arch. Dis. Child.
     </isoabbreviation>
    </journal>
    <articletitle>
     Double blind, placebo controlled study of nedocromil sodium in asthma.
    </articletitle>
    <pagination>
     <medlinepgn>
      193-7
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext>
      After a two week baseline, 209 asthmatic children (mean age 10 years, range 6-17) were randomly allocated to receive 4 mg nedocromil sodium (n = 110) or placebo (n = 99) four times daily for 12 weeks in addition to their current treatment. The children completed daily diary cards and visited the clinic at four week intervals. Statistically significant differences in favour of nedocromil sodium were seen for clinician assessment of asthma severity and diary card symptom scores, pulmonary function and inhaled beta 2 bronchodilator use. Total symptom score decreased by 50% from baseline in the nedocromil sodium group and by 9% in the placebo group during the final four weeks. Nedocromil sodium was considered very or moderately effective by 78% of children/parents (placebo 59%) and 73% of clinicians (placebo 50%). Nausea, headache and sleepiness, and dyspnoea led to withdrawal of one child from nedocromil sodium and placebo treatments, respectively. Reports of sore throat and headache were marginally greater with the nedocromil sodium treatment. It is concluded that nedocromil sodium was both effective and safe in the treatment of asthma in children.
     </abstracttext>
    </abstract>
    <affiliation>
     Paediatric Clinic, University of Bari, Italy.
    </affiliation>
    <authorlist completeyn="N">
     <author validyn="Y">
      <lastname>
       Armenio
      </lastname>
      <forename>
       L
      </forename>
      <initials>
       L
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Baldini
      </lastname>
      <forename>
       G
      </forename>
      <initials>
       G
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Bardare
      </lastname>
      <forename>
       M
      </forename>
      <initials>
       M
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Boner
      </lastname>
      <forename>
       A
      </forename>
      <initials>
       A
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Burgio
      </lastname>
      <forename>
       R
      </forename>
      <initials>
       R
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Cavagni
      </lastname>
      <forename>
       G
      </forename>
      <initials>
       G
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       La Rosa
      </lastname>
      <forename>
       M
      </forename>
      <initials>
       M
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Marcucci
      </lastname>
      <forename>
       F
      </forename>
      <initials>
       F
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Miraglia del Giudice
      </lastname>
      <forename>
       M
      </forename>
      <initials>
       M
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Pulejo
      </lastname>
      <forename>
       M R
      </forename>
      <initials>
       MR
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Clinical Trial
     </publicationtype>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Randomized Controlled Trial
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     ENGLAND
    </country>
    <medlineta>
     Arch Dis Child
    </medlineta>
    <nlmuniqueid>
     0372434
    </nlmuniqueid>
    <issnlinking>
     0003-9888
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Anti-Inflammatory Agents, Non-Steroidal
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Quinolones
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      69049-73-6
     </registrynumber>
     <nameofsubstance>
      Nedocromil
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    AIM
   </citationsubset>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Exp Allergy. 1990 Nov;20(6):683-8
     </refsource>
     <pmid version="1">
      1964620
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Allergy Clin Immunol. 1987 May;79(5):734-40
     </refsource>
     <pmid version="1">
      3106449
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Chest. 1990 Jun;97(6):1299-306
     </refsource>
     <pmid version="1">
      2161328
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Clin Pharmacol. 1990 May;29(5):525-31
     </refsource>
     <pmid version="1">
      2161678
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Br J Clin Pharmacol. 1990 Sep;30(3):371-6
     </refsource>
     <pmid version="1">
      2171616
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Pediatr Med Chir. 1990 Mar-Apr;12(2):157-60
     </refsource>
     <pmid version="1">
      2172934
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Immunol. 1986 Dec 15;137(12):3941-5
     </refsource>
     <pmid version="1">
      2431049
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Allergy. 1988 May;43(4):268-76
     </refsource>
     <pmid version="1">
      2455454
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Allergy. 1988 Jul;18(4):375-82
     </refsource>
     <pmid version="1">
      2458198
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Allergy. 1989 Jan;62(1):38-41
     </refsource>
     <pmid version="1">
      2536255
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Allergy Clin Immunol. 1989 May;83(5):985-90
     </refsource>
     <pmid version="1">
      2541193
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Exp Allergy. 1989 May;19(3):285-91
     </refsource>
     <pmid version="1">
      2544248
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Eur Respir J Suppl. 1989 Jun;6:561s-565s
     </refsource>
     <pmid version="1">
      2553033
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Curr Med Res Opin. 1989;11(8):533-42
     </refsource>
     <pmid version="1">
      2553335
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Respiration. 1989;55(3):181-5
     </refsource>
     <pmid version="1">
      2554440
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Drugs. 1987 Nov;34(5):560-77
     </refsource>
     <pmid version="1">
      2826101
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Int Arch Allergy Appl Immunol. 1988;85(2):232-7
     </refsource>
     <pmid version="1">
      2828242
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Allergy. 1988 Aug;43(6):449-53
     </refsource>
     <pmid version="1">
      2847578
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Int Arch Allergy Appl Immunol. 1987;82(1):108-10
     </refsource>
     <pmid version="1">
      3026967
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Allergy Proc. 1991 Jan-Feb;12(1):5-9
     </refsource>
     <pmid version="1">
      2040448
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adolescent
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Anti-Inflammatory Agents, Non-Steroidal
     </descriptorname>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Asthma
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
     <qualifiername majortopicyn="N">
      physiopathology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Child
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Double-Blind Method
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Forced Expiratory Volume
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Lung
     </descriptorname>
     <qualifiername majortopicyn="N">
      physiopathology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Male
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Nedocromil
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Patient Compliance
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Patient Satisfaction
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Peak Expiratory Flow Rate
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Quinolones
     </descriptorname>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Time Factors
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Treatment Outcome
     </descriptorname>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC1029233
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1993
     </year>
     <month>
      2
     </month>
     <day>
      1
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      1993
     </year>
     <month>
      2
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1993
     </year>
     <month>
      2
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     8386917
    </articleid>
    <articleid idtype="pmc">
     PMC1029233
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

